Abstract
The benzodiazepine receptor antagonist 3-hydroxymethyl-β-carboline, which blocks several of the pharmacological actions of benzodiazepines, induces a dose-dependent increase in sleep latency in the rat. Furthermore, at a low dose that by itself does not affect sleep, 3-hydroxymethyl-β-carboline blocks sleep induction by a large dose of flurazepam. The benzodiazepine receptor may play a role in both the physiological regulation and pharmacological induction of sleep.
| Original language | English |
|---|---|
| Pages (from-to) | 414-416 |
| Number of pages | 3 |
| Journal | Science |
| Volume | 219 |
| Issue number | 4583 |
| DOIs | |
| State | Published - 1983 |
Fingerprint
Dive into the research topics of 'A benzodiazepine receptor antagonist decreases sleep and reverses the hypnotic actions of flurazepam'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver